Media Advisory: BTCS to participate in upcoming fireside chat
Get Alerts BTCS Hot Sheet
Join SI Premium – FREE
CEO Charles Allen to speak with Analyst John Roy on August 6
SILVER SPRING, Md., July 31, 2025 (GLOBE NEWSWIRE) -- BTCS Inc. (Nasdaq: BTCS) (“BTCS” or the “Company”), a blockchain technology-focused company, short for Blockchain Technology Consensus Solutions, is pleased to be participating in an upcoming event.
| What: | Fireside chat between BTCS CEO Charles Allen and Water Tower Research Analyst John Roy | |
| When: | August 6, 2025 at 1 p.m. ET | |
| Where: | Media and Investors are invited to register to attend the virtual event here. | |
A replay will be available here following the session.
About BTCS:
BTCS Inc. (“BTCS” or the “Company”), short for Blockchain Technology Consensus Solutions, is a U.S.-based Ethereum-first blockchain technology company committed to driving scalable revenue and ETH accumulation through its hallmark strategy, the DeFi/TradFi Accretion Flywheel, an integrated approach to capital formation and blockchain infrastructure. By combining decentralized finance (“DeFi”) and traditional finance (“TradFi”) mechanisms with its blockchain infrastructure operations, comprising NodeOps (staking) and Builder+ (block building), BTCS offers one of the most sophisticated opportunities for leveraged ETH exposure, driven by scalable revenue generation and a yield-focused ETH accumulation strategy. Discover how BTCS offers operational and financial leveraged exposure to Ethereum through the public markets at www.btcs.com.
For more information follow us on:
Twitter: https://x.com/NasdaqBTCS
LinkedIn: https://www.linkedin.com/company/nasdaq-btcs
Facebook: https://www.facebook.com/NasdaqBTCS
Investor Relations:
Charles Allen – CEO
X (formerly Twitter): @Charles_BTCS
Email: [email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apollo Group`s interim condensed consolidated financial statements for the 3 months of 2026/2027 (unaudited)
- Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA
- Crypto News: Pepeto Announces Presale Stage Closed Early as the XRP Price Prediction Targets $14
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share